Education
About Us
Working with TipRanks
Follow Us
NeonMind Biosciences Inc (TSE:LCR)
:LCR
Total Valuation
NeonMind Biosciences Inc has a market cap or net worth of C$4.16M. The enterprise value is C$3.64M.
Market CapC$4.16M
Enterprise ValueC$3.64M
Share Statistics
NeonMind Biosciences Inc has 92,499,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,499,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NeonMind Biosciences Inc’s return on equity (ROE) is 2.76 and return on invested capital (ROIC) is -275.84%.
Return on Equity (ROE)2.76
Return on Assets (ROA)-1.61
Return on Invested Capital (ROIC)-275.84%
Return on Capital Employed (ROCE)-3.25
Revenue Per Employee0.00
Profits Per Employee-61.83K
Employee Count28
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NeonMind Biosciences Inc is ―. NeonMind Biosciences Inc’s PEG ratio is 0.45.
PE Ratio―
PS Ratio0.00
PB Ratio-9.40
Price to Fair Value-9.40
Price to FCF-6.04
Price to Operating Cash Flow-4.53
PEG Ratio0.45
Income Statement
In the last 12 months, NeonMind Biosciences Inc had revenue of 0.00 and earned -1.75M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit0.00
Operating Income-1.33M
Pretax Income-1.76M
Net Income-1.75M
EBITDA-1.58M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -988.66K and capital expenditures 4.00, giving a free cash flow of -988.65K billion.
Operating Cash Flow-988.66K
Free Cash Flow-988.65K
Free Cash Flow per Share-0.01
Dividends & Yields
NeonMind Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.19
52-Week Price Change125.00%
50-Day Moving Average0.04
200-Day Moving Average0.05
Relative Strength Index (RSI)47.04
Average Volume (3m)290.69K
Important Dates
NeonMind Biosciences Inc upcoming earnings date is Mar 3, 2026, Before Open (Confirmed).
Last Earnings DateNov 28, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
NeonMind Biosciences Inc as a current ratio of 0.40, with Debt / Equity ratio of -178.73%
Current Ratio0.40
Quick Ratio0.40
Debt to Market Cap0.19
Net Debt to EBITDA-0.61
Interest Coverage Ratio-7.24
Taxes
In the past 12 months, NeonMind Biosciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeonMind Biosciences Inc EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -7.01.
EV to Sales0.00
EV to EBITDA-4.40
EV to Free Cash Flow-7.01
EV to Operating Cash Flow-7.01
Balance Sheet
NeonMind Biosciences Inc has C$206.03K in cash and marketable securities with C$1.14M in debt, giving a net cash position of -C$929.24K billion.
Cash & Marketable SecuritiesC$206.03K
Total DebtC$1.14M
Net Cash-C$929.24K
Net Cash Per Share-C$0.01
Tangible Book Value Per Share>-C$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NeonMind Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast2.62%